B-lymphocyte marker CD19
2025-03-28
CD19, a B-lymphocyte antigen (CD19), acts as a co-peptide of the B-cell antigen receptor complex (BCR) on B lymphocytes. CD19 is a biomarker for normal and neoplastic B cells, as w...
Development of bispecific antibody-drug conjugates targeting EpCAM and CLDN3
2025-03-27
BackgroundEpithelial cell adhesion molecule (EpCAM), a tumor antigen targeted by antibody-drug conjugates (ADCs), is highly expressed in many epithelial cancers. However, clinical ...
The chemokine receptor CCR4
2025-03-27
CCR4, also known as CD194 or CMKBR4, is a chemokine receptor. It is a G protein-coupled receptor (GPCR) used for signal transduction, causing cell chemotaxis and activation. CCR4 i...
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
2025-03-25
BackgroundTumor-infiltrating regulatory T cells (TI-Tregs) are key components of the tumor microenvironment (TME) that promote immune evasion and drive tumor progression. Although ...
The folate receptor FOLR1
2025-03-24
Folate receptor α (FOLR1 / FRα) is a high-affinity folate-binding protein and one of the major folate transporters. Overexpression of FOLR1 is often associated with accelerated can...
Don't eat my signaling protein CD47
2025-03-21
The leukocyte surface antigen CD47, also known as MER6 or IAP, is a ligand for signal regulatory protein α (SIRPα). Its extracellular domain (ECD) is a cell surface self-marker tha...
Macrophage migration inhibitor MIF
2025-03-20
Macrophage migration inhibitory factor (MIF) has been discovered as an inhibitor of T lymphocyte induction and acts as a pleiotropic proinflammatory cytokine. It is involved in var...